{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dermatologic+Complications", "query": { "condition": "Dermatologic Complications" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Dermatologic+Complications&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T00:07:49.088Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01393821", "title": "Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dermatologic Complications", "Malignant Neoplasm", "Pain" ], "interventions": [ { "name": "menadione topical lotion", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "management of therapy complications", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2012-01-23", "completion_date": "2018-07-14", "has_results": true, "last_update_posted_date": "2025-05-16", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 2, "location_summary": "Phoenix, Arizona • Rochester, Minnesota", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01393821" }, { "nct_id": "NCT04580472", "title": "Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Surgical Site Infection" ], "interventions": [ { "name": "Cephalexin", "type": "DRUG" }, { "name": "Placebo capsules", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Carilion Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 574, "start_date": "2020-10-01", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-03-25", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 1, "location_summary": "Roanoke, Virginia", "locations": [ { "city": "Roanoke", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04580472" }, { "nct_id": "NCT01867294", "title": "Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Malignant Neoplasm", "Dermatologic Complication" ], "interventions": [ { "name": "Doxycycline", "type": "DRUG" }, { "name": "Management of Therapy Complications", "type": "PROCEDURE" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Spironolactone", "type": "DRUG" }, { "name": "Sunscreen", "type": "DRUG" }, { "name": "Therapeutic Hydrocortisone", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2012-08-31", "completion_date": "2014-06-13", "has_results": true, "last_update_posted_date": "2020-01-09", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 5, "location_summary": "Urbana, Illinois • Des Moines, Iowa • Wichita, Kansas + 2 more", "locations": [ { "city": "Urbana", "state": "Illinois" }, { "city": "Des Moines", "state": "Iowa" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Saint Cloud", "state": "Minnesota" }, { "city": "Marshfield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01867294" }, { "nct_id": "NCT01416688", "title": "S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer", "Dermatologic Complications", "Lung Cancer", "Therapy-related Toxicity" ], "interventions": [ { "name": "assessment of therapy complications", "type": "PROCEDURE" }, { "name": "psychosocial assessment and care", "type": "PROCEDURE" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 146, "start_date": "2011-11-15", "completion_date": "2019-04-08", "has_results": false, "last_update_posted_date": "2022-12-15", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 113, "location_summary": "Tucson, Arizona • Castro Valley, California • Duarte, California + 78 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Castro Valley", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Dublin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01416688" }, { "nct_id": "NCT00438659", "title": "Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer", "Dermatologic Complications", "Radiation Toxicity", "Skin Reactions Secondary to Radiation Therapy" ], "interventions": [ { "name": "mometasone furoate", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "North Central Cancer Treatment Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 176, "start_date": "2007-08", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2016-08-01", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 189, "location_summary": "Aurora, Illinois • Bloomington, Illinois • Canton, Illinois + 116 more", "locations": [ { "city": "Aurora", "state": "Illinois" }, { "city": "Bloomington", "state": "Illinois" }, { "city": "Canton", "state": "Illinois" }, { "city": "Carthage", "state": "Illinois" }, { "city": "Eureka", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00438659" }, { "nct_id": "NCT03848962", "title": "Collection and Distribution of Biospecimens for Novel Research Uses", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer", "Healthy", "Gastrointestinal Complication", "Autoimmune Diseases", "Infectious Disease", "Women's Health: High-Risk Pregnancy", "Dermatologic Disease", "Blood Disease" ], "interventions": [], "intervention_types": [], "sponsor": "iSpecimen Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Month", "maximum_age": "89 Years", "sex": "ALL", "summary": "1 Month to 89 Years" }, "enrollment_count": 10000, "start_date": "2016-06-30", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2022-11-09", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 2, "location_summary": "Huntsville, Alabama • Lexington, Massachusetts", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Lexington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03848962" }, { "nct_id": "NCT00498992", "title": "Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dermatologic Complications", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "collagen/aloe vera/vitamin E/lidocaine topical hydrogel", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Ingalls Memorial Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2006-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-09-20", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 1, "location_summary": "Harvey, Illinois", "locations": [ { "city": "Harvey", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00498992" }, { "nct_id": "NCT07128966", "title": "Direct to Patient Minimal Risk Biospecimen and Data Collection Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy", "Lupus", "Celiac", "Kidney Disease", "Chronic", "Dermatologic" ], "interventions": [ { "name": "Observation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Joined Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 100000, "start_date": "2025-04-01", "completion_date": "2036-09-01", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 1, "location_summary": "Lexington, Massachusetts", "locations": [ { "city": "Lexington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07128966" }, { "nct_id": "NCT01347736", "title": "Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dermatologic Complications", "Pain", "Viral Infection" ], "interventions": [ { "name": "scrambler therapy", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "dermatologic complications management/prevention", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2011-03", "completion_date": "2014-11-07", "has_results": false, "last_update_posted_date": "2018-04-04", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01347736" }, { "nct_id": "NCT02003404", "title": "Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Dermatologic Complications" ], "interventions": [ { "name": "Control Abdominal Skin", "type": "DEVICE" }, { "name": "Peristomal Abdominal Skin", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Hollister Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2013-11", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2016-11-11", "last_synced_at": "2026-05-22T00:07:49.088Z", "location_count": 1, "location_summary": "La Grange Park, Illinois", "locations": [ { "city": "La Grange Park", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02003404" } ] }